FIELD: biotechnology, microbiology. SUBSTANCE: protein exhibiting pore-forming function in cellular wall of meliodosis pathogen and purified from cytoplasmic proteins and peptidoglycan is administrated to meliodosis-sensitive animal by subcutaneous route at dose 880-7000 mcg/mg animal mass. Immunization is carried out by schedule that is experimentally adopted to each animal species. Protective effect estimation is carried out by subcutaneous infection of animals with virulent culture of meliodosis microorganism. Method provides survival 100% white rats infected with subcutaneous dose ID50 of agar culture of high-virulent strain of Pseudomonas pseudomallei CN-141. EFFECT: improved method of prophylaxis. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIGENIC PREPARATIONS FOR PREVENTING GLANDERS IN PEOPLE AND ANIMALS | 2004 |
|
RU2262949C1 |
METHOD FOR ISOLATION OF PROTEIN 39 KDA FROM MELIODOSIS PATHOGEN EXTERNAL MEMBRANE | 2002 |
|
RU2208445C1 |
ANTIGENIC COMPOSITION OF PLAGUE CHEMICAL VACCINE | 2001 |
|
RU2190424C1 |
METHOD FOR IMMUNOPROPHYLAXIS OF EXPERIMENTAL PSEUDOCHOLERA WITH ENTRAPPED ANTIGENS Burkholderia pseudomallei | 2008 |
|
RU2373955C1 |
METHOD OF PREPARING PROTECTIVE GLYCOPROTEIN OF MELIOIDOSIS PATHOGEN | 1996 |
|
RU2109520C1 |
METHOD FOR INCREASE OF MELIOIDOSIS ANTIGENS PROTECTIVITY BY CYTOKINES | 2008 |
|
RU2376031C1 |
METHOD FOR DETERMINING BURKHOLDERIA MALLEI CAPSULAR ANTIGEN IMMUNOGENICITY LEVEL | 2005 |
|
RU2293993C1 |
METHOD FOR PRESENTATION OF VIRAL ANTIGEN IN IMMUNE SYSTEM OF HOST BASED ON PROTEASOME-MEDIATED TECHNOLOGY DESIGNATED FOR DEVELOPMENT OF METHODS OF BIOLOGICAL PROTECTION | 2004 |
|
RU2275937C1 |
METHOD FOR OBTAINING ANTITULAREMIC SERUM AND METHOD FOR OBTAINING A DRY ERYTHROCYTIC TULAREMIC IMMUNOGLOBULIN TEST KIT | 2002 |
|
RU2240822C2 |
METHOD FOR MODELING PULMONARY MELIOIDOSIS | 1999 |
|
RU2157538C1 |
Authors
Dates
1996-08-20—Published
1992-11-17—Filed